Pathology of Castleman Disease
- 1 February 2018
- journal article
- research article
- Published by Elsevier BV in Hematology/Oncology Clinics of North America
- Vol. 32 (1), 37-52
- https://doi.org/10.1016/j.hoc.2017.09.004
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Surgery in Castleman's DiseaseAnnals of Surgery, 2012
- Castleman's Disease: Systematic Analysis of 416 Patients from the LiteratureThe Oncologist, 2011
- B-Cell Lymphoma With Hyaline Vascular Castleman Disease–Like FeaturesAmerican Journal of Clinical Pathology, 2011
- Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti–IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman diseaseBlood, 2008
- Interfollicular Hodgkin's lymphoma and Castleman's diseaseHistopathology, 2006
- Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman diseaseBlood, 2005
- Lack of Cytogenetic Abnormalities in Castlemanʼs Disease*Southern Medical Journal, 2001
- Hodgkin's disease presenting with the histological features of Castleman's diseaseHistopathology, 1991
- Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.JCI Insight, 1990
- A systemic lymphoproliferative disorder with morphologic features of Castlemanʼs diseaseThe American Journal of Surgical Pathology, 1983